InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: BioInvestor3 post# 382927

Tuesday, 07/12/2022 9:20:16 AM

Tuesday, July 12, 2022 9:20:16 AM

Post# of 426487
Bio...QUOTE...article from Mar1, 2021..."During 2019, Pfizer’s Lipitor generated nearly two billion U.S. dollars of revenue."...

This is an example of what Pfizer could do with an AG Vascepa.

The price of Lipitor is low, but the volume is great, even in the face of MANY generic competitors.

A once or twice a day, patent protected, Lipitor-Vascepa combo drug would also help revenues...which would flow directly to Pfizer's bottom line.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News